NCT06839664View on ClinicalTrials.gov

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

PHASE3RecruitingINTERVENTIONAL
Enrollment

610

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

January 27, 2026

Study Completion Date

February 27, 2026

Conditions
OverweightObesity
Interventions
DRUG

HS-20094 injection

Administered SC

DRUG

Placebo injection

Administered SC

Trial Locations (1)

Unknown

RECRUITING

Peking University People's Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY